Moderna Aims To Revolutionize Modern Medicine With A New Class Of Drugs [Seeking Alpha]
Vertex Pharmaceuticals Incorporated (VRTX)
Last vertex pharmaceuticals incorporated earnings: 4/29 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.vrtx.com
Company Research
Source: Seeking Alpha
Moderna Aims To Revolutionize Modern Medicine With A New Class Of Drugs Summary moderna had the largest IPO in biotech history. mRNA drugs may bring about a paradigm-shift in modern medicine. Personalized cancer vaccines may become a reality in the not-too-distant future. With over 20 candidate drugs in their pipeline consisting of immuno-oncology, rare diseases, and vaccines for unmet medical needs, moderna is poised to be the leader in a new class of drugs. Messenger RNA therapeutics company, MRNA AstraZeneca AZN Merck MRK Vertex VRTX Currently, no mRNA drugs have been approved by the FDA. However, there is incredible growth potential if moderna gets this right. Globally, according to a ResearchAndMarkets report mRNA Drugs: The Science The flow of information from our DNA goes from DNA to mRNA to protein. The mRNA is transcribed from DNA, and then translated into proteins, which are the functional molecules that drive all biochemical processes in the human body such as growth, metab
Show less
Read more
Impact Snapshot
Event Time:
VRTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VRTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VRTX alerts
High impacting Vertex Pharmaceuticals Incorporated news events
Weekly update
A roundup of the hottest topics
VRTX
News
- The Americas’ Fastest Growing Companies [Financial Times (FT.com) (UK)]Financial Times
- Its blockbuster cystic fibrosis treatment costs $300,000 a year. Now Vertex wants to solve the opioid crisis [Financial Times (FT.com) (UK)]Financial Times
- Vertex Pharmaceuticals (VRTX) Falls More Steeply Than Broader Market: What Investors Need to Know [Yahoo! Finance]Yahoo! Finance
- 2 Fantastic Growth Stocks to Buy Right Now [Yahoo! Finance]Yahoo! Finance
- Walgreens expands specialty pharmacy with unit dedicated to cell and gene therapies [Seeking Alpha]Seeking Alpha
VRTX
Earnings
- 2/5/24 - Beat
VRTX
Sec Filings
- 4/17/24 - Form 4
- 4/16/24 - Form PX14A6G
- 4/11/24 - Form SC
- VRTX's page on the SEC website